1) proliferative diabetic retinopathy
增生性糖尿病视网膜病
1.
Pars plana vitrectomy combined with phacoemulsification and intraocular lens implantation for proliferative diabetic retinopathy;
玻璃体切割联合超声乳化人工晶体植入术治疗增生性糖尿病视网膜病变
2) Proliferative diabetic retinopathy
增生性糖尿病性视网膜病
1.
AIM:To investigate patient assessed visual function and visual acuity after treatment with the unselective anti-VEGF inhibitor bevacizumab in diabetic macular edema after scatter laser photocoagulation due to proliferative diabetic retinopathy(PDR) .
目的:增生性糖尿病性视网膜病播散性视网膜激光光凝后,用非选择性抗VEGF抑制剂贝伐单抗治疗糖尿病性黄斑水肿,调查患者自我评估的视功能及视力。
3) Proliferative Diabetic Retinopathy
增生性糖尿病性视网膜病变
1.
Clinical Application of Fiberoptic-Free Bimanual Vitrectomy with A Novel System in Proliferative Diabetic Retinopathy;
无光导-双手法玻璃体切割术在增生性糖尿病性视网膜病变中的应用
2.
Vitrectomy combined with phacoemulsification for proliferative diabetic retinopathy
玻璃体切除术联合晶状体手术治疗增生性糖尿病性视网膜病变
4) proliferative diabetic retinopathy
增生性糖尿病视网膜病变
1.
Different intraocular tamponade during vitrectomy on proliferative diabetic retinopathy;
增生性糖尿病视网膜病变患者玻璃体手术不同眼内填充物的效果分析
2.
Expression of MMP-2 and MMP-9 in vitrectomy specimens with proliferative diabetic retinopathy;
增生性糖尿病视网膜病变玻璃体切除物中MMP-2和MMP-9的表达
3.
Surgical treatment of proliferative diabetic retinopathy.;
增生性糖尿病视网膜病变的手术治疗观察
5) proliferative diabetic retinopathy(PDR)
增生型糖尿病[性]视网膜病变
6) PDR
增殖性糖尿病性视网膜病变
1.
Objective:To explore the effect and the filling material of vitrectomy combining with laser on the treatment of PDR.
目的:观察分析玻璃体切割联合激光治疗增殖性糖尿病性视网膜病变的疗效及充填材料选择。
2.
Objective:To assess the incidence of apoptosis in epiretinal membranes from eyes with proliferative vitreoretinopathy(PVR),proliferative diabetic retinopathy (PDR),and macular pucker (MP) and to further investigate the potential involvement of key executors of apoptosis.
方法 :2 3例增殖性玻璃体视网膜病变 (PVR) ,增殖性糖尿病性视网膜病变 (PDR) ,黄斑裂孔 (MH)及黄斑前膜 (MP)的视网膜前膜 (epiretinalmem brane,ERM )由玻璃体切割术中取得。
补充资料：淋巴结病和窦性组织细胞增生症
淋巴结病和窦性组织细胞增生症
〖HT5”SS〗lymplh ?adenopathy and sinus histiocytosis
属Ⅱ类组织细胞增生症。其特点是发热、白细胞增多、颈淋巴结肿大。病理改变为淋巴结包膜下及髓窦组织细胞增生，光镜下很似朗格汉斯细胞组织细胞增生症，但电镜下不见Birbeck颗粒，CDIa阴性。病变不侵犯骨骼、肝、脾、肺、皮肤等组织，仅限于淋巴结。可有暂时性免疫功能低下。非恶性肿瘤。预后较好。对有严重淋巴结破坏者，化疗效果较好。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条